Literature DB >> 9342374

Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia.

M Kaplan1, P Renbaum, E Levy-Lahad, C Hammerman, A Lahad, E Beutler.   

Abstract

Severe jaundice leading to kernicterus or death in the newborn is the most devastating consequence of glucose-6-phosphate dehydrogenase (EC 1.1.1.49; G-6-PD) deficiency. We asked whether the TA repeat promoter polymorphism in the gene for uridinediphosphoglucuronate glucuronosyltransferase 1 (EC 2.4.1.17; UDPGT1), associated with benign jaundice in adults (Gilbert syndrome), increases the incidence of neonatal hyperbilirubinemia in G-6-PD deficiency. DNA from term neonates was analyzed for UDPGT1 polymorphism (normal homozygotes, heterozygotes, variant homozygotes), and for G-6-PD Mediterranean deficiency. The variant UDPGT1 promoter allele frequency was similar in G-6-PD-deficient and normal neonates. Thirty (22.9%) G-6-PD deficient neonates developed serum total bilirubin >/= 257 micromol/liter, vs. 22 (9.2%) normals (P = 0.0005). Of those with the normal homozygous UDPGT1 genotype, the incidence of hyperbilirubinemia was similar in G-6-PD-deficients and controls (9.7% and 9.9%). In contrast, in the G-6-PD-deficient neonates, those with the heterozygous or homozygous variant UDPGT1 genotype had a higher incidence of hyperbilirubinemia than corresponding controls (heterozygotes: 31.6% vs. 6.7%, P < 0.0001; variant homozygotes: 50% vs. 14.7%, P = 0.02). Among G-6-PD-deficient infants the incidence of hyperbilirubinemia was greater in those with the heterozygous (31.6%, P = 0.006) or variant homozygous (50%, P = 0.003) UDPGT1 genotype than in normal homozygotes. In contrast, among those normal for G-6-PD, the UDPGT1 polymorphism had no significant effect (heterozygotes: 6.7%; variant homozygotes: 14.7%). Thus, neither G-6-PD deficiency nor the variant UDPGT1 promoter, alone, increased the incidence of hyperbilirubinemia, but both in combination did. This gene interaction may serve as a paradigm of the interaction of benign genetic polymorphisms in the causation of disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9342374      PMCID: PMC23725          DOI: 10.1073/pnas.94.22.12128

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Alternative splicing of human glucose-6-phosphate dehydrogenase messenger RNA in different tissues.

Authors:  A Hirono; E Beutler
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

2.  Tissue enzyme levels in erythrocyte glucose-6-phosphate dehydrogenase deficiency.

Authors:  T K Chan; D Todd; C C Wong
Journal:  J Lab Clin Med       Date:  1965-12

3.  Gilbert's syndrome: diagnosis by typical serum bilirubin pattern.

Authors:  A Sieg; A Stiehl; R Raedsch; D Ullrich; B Messmer; B Kommerell
Journal:  Clin Chim Acta       Date:  1986-01-15       Impact factor: 3.786

4.  Hidden risks: early discharge and bilirubin toxicity due to glucose 6-phosphate dehydrogenase deficiency.

Authors:  M G MacDonald
Journal:  Pediatrics       Date:  1995-10       Impact factor: 7.124

Review 5.  G6PD deficiency.

Authors:  E Beutler
Journal:  Blood       Date:  1994-12-01       Impact factor: 22.113

6.  A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini.

Authors:  J K Ritter; F Chen; Y Y Sheen; H M Tran; S Kimura; M T Yeatman; I S Owens
Journal:  J Biol Chem       Date:  1992-02-15       Impact factor: 5.157

7.  Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert's syndrome.

Authors:  G Monaghan; M Ryan; R Seddon; R Hume; B Burchell
Journal:  Lancet       Date:  1996-03-02       Impact factor: 79.321

Review 8.  Severe neonatal jaundice associated with glucose-6-phosphate dehydrogenase deficiency: pathogenesis and global epidemiology.

Authors:  T Valaes
Journal:  Acta Paediatr Suppl       Date:  1994-03

9.  Neonatal hyperbilirubinemia associated with glucose-6-phosphate dehydrogenase deficiency in Sephardic-Jewish neonates: incidence, severity, and the effect of phototherapy.

Authors:  M Kaplan; A Abramov
Journal:  Pediatrics       Date:  1992-09       Impact factor: 7.124

10.  Interactions of glucose-6-phosphate dehydrogenase deficiency with drug acetylation and hydroxylation reactions.

Authors:  A M Magon; R M Leipzig; V G Zannoni; G J Brewer
Journal:  J Lab Clin Med       Date:  1981-06
View more
  34 in total

Review 1.  Glucuronidation in humans. Pharmacogenetic and developmental aspects.

Authors:  S N de Wildt; G L Kearns; J S Leeder; J N van den Anker
Journal:  Clin Pharmacokinet       Date:  1999-06       Impact factor: 6.447

Review 2.  Gilbert syndrome.

Authors:  Andrew Fretzayas; Maria Moustaki; Olga Liapi; Themistocles Karpathios
Journal:  Eur J Pediatr       Date:  2011-12-09       Impact factor: 3.183

3.  William A Silverman lecture.

Authors:  D K Stevenson
Journal:  J Perinatol       Date:  2013-08-22       Impact factor: 2.521

4.  Association of neonatal hyperbilirubinemia in breast-fed infants with UGT1A1 or SLCOs polymorphisms.

Authors:  Hiroko Sato; Toshihiko Uchida; Kentaro Toyota; Tomohiro Nakamura; Gen Tamiya; Miyako Kanno; Taeko Hashimoto; Masashi Watanabe; Kuraaki Aoki; Kiyoshi Hayasaka
Journal:  J Hum Genet       Date:  2014-11-13       Impact factor: 3.172

5.  XRCC1 polymorphisms associated with survival among Chinese bladder cancer patients receiving epirubicin and mitomycin C.

Authors:  Xiaheng Deng; Xiaolei Zhang; Yidong Cheng; Xiao Yang; Ruizhe Zhao; Xuzhong Liu; Xiao Li; Chao Qin; Qiang Lu; Changjun Yin
Journal:  Tumour Biol       Date:  2015-01-25

6.  Neonatal bilirubin production-conjugation imbalance: effect of glucose-6-phosphate dehydrogenase deficiency and borderline prematurity.

Authors:  M Kaplan; M Muraca; H J Vreman; C Hammerman; M T Vilei; F F Rubaltelli; D K Stevenson
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-03       Impact factor: 5.747

7.  Relation between Neonatal Icter and Gilbert Syndrome in Gloucose-6-Phosphate Dehydrogenase Deficient Subjects.

Authors:  Yadollah Zahedpasha; Mousa Ahmadpour; Haleh Akhavan Niaki; Ehsan Alaee
Journal:  J Clin Diagn Res       Date:  2014-03-15

Review 8.  Metalloporphyrins in the management of neonatal hyperbilirubinemia.

Authors:  David K Stevenson; Ronald J Wong
Journal:  Semin Fetal Neonatal Med       Date:  2009-12-16       Impact factor: 3.926

Review 9.  Inherited disorders of bilirubin clearance.

Authors:  Naureen Memon; Barry I Weinberger; Thomas Hegyi; Lauren M Aleksunes
Journal:  Pediatr Res       Date:  2015-11-23       Impact factor: 3.756

10.  Antioxidant vitamins and hyperbilirubinemia in neonates.

Authors:  Khalid K Abdul-Razzak; Mohamad K Nusier; Ahmad D Obediat; Ahmad M Salim
Journal:  Ger Med Sci       Date:  2007-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.